ArrowArtboardCreated with Sketch.Title ChevronTitle ChevronIcon FacebookIcon LinkedinIcon Mail ContactPath LayerIcon MailPositive ArrowIcon Print

SoftBank to offer $21 at-home coronavirus tests in Japan

The saliva-screening exam is currently limited to public and private sector workers

A worker processes a sample at a coronavirus testing facility run by a SoftBank Group subsidiary in Chiba, near Tokyo. (Photo by Shihoko Nakaoka)

TOKYO -- The general public in Japan will be able to receive low-cost at-home coronavirus testing from SoftBank Group, which until now had only offered its PCR screening to companies and local governments.

Saliva-based polymerase chain reaction tests will be available to asymptomatic people beginning in March for an expected cost of 2,200 yen ($21), including taxes but excluding shipping and other costs -- the same price SoftBank charges to corporate and public-sector users.

Sponsored Content

About Sponsored Content This content was commissioned by Nikkei's Global Business Bureau.

Discover the all new Nikkei Asia app

  • Take your reading anywhere with offline reading functions
  • Never miss a story with breaking news alerts
  • Customize your reading experience

Nikkei Asian Review, now known as Nikkei Asia, will be the voice of the Asian Century.

Celebrate our next chapter
Free access for everyone - Sep. 30

Find out more